Movatterモバイル変換


[0]ホーム

URL:


CN106565593B - A kind of preparation method of Ceritinib intermediate - Google Patents

A kind of preparation method of Ceritinib intermediate
Download PDF

Info

Publication number
CN106565593B
CN106565593BCN201510651796.1ACN201510651796ACN106565593BCN 106565593 BCN106565593 BCN 106565593BCN 201510651796 ACN201510651796 ACN 201510651796ACN 106565593 BCN106565593 BCN 106565593B
Authority
CN
China
Prior art keywords
isopropoxy
tolyl
bromo
acetamide
benzyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CN201510651796.1A
Other languages
Chinese (zh)
Other versions
CN106565593A (en
Inventor
潘勇
夏晓丽
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
CHANGZHOU YONGYI BIO-PHARMACEUTICAL Co Ltd
Original Assignee
CHANGZHOU YONGYI BIO-PHARMACEUTICAL Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by CHANGZHOU YONGYI BIO-PHARMACEUTICAL Co LtdfiledCriticalCHANGZHOU YONGYI BIO-PHARMACEUTICAL Co Ltd
Priority to CN201510651796.1ApriorityCriticalpatent/CN106565593B/en
Publication of CN106565593ApublicationCriticalpatent/CN106565593A/en
Application grantedgrantedCritical
Publication of CN106565593BpublicationCriticalpatent/CN106565593B/en
Activelegal-statusCriticalCurrent
Anticipated expirationlegal-statusCritical

Links

Classifications

Landscapes

Abstract

The present invention relates to a kind of preparation methods of Ceritinib intermediate, comprising: (1) the bromo- 2- isopropoxy -5- methylaniline of 4- is reacted with aceticanhydride generates N- (the bromo- 2- isopropoxy -5- tolyl of 4-);(2) N- benzyl -4- piperidones is generated by 4- piperidines reactive ketone;(3) N- (the bromo- 2- isopropoxy -5- tolyl of 4-) acetamide carries out docking with N- benzyl -4- piperidones and reacts;(4) preceding step reaction product is subjected to decarboxylation reaction;(5) by N- (4- (1- benzyl -1,2,3,6- tetrahydropyridine -4- base) -2- isopropoxy -5- tolyl) acetamide generates final product Ceritinib intermediate in the presence of a catalyst, the present invention develops the new preparation method of Ceritinib intermediate, the synthetic route is at low cost, and reaction condition is easily controllable as mild as a dove, is more suitable for large-scale industrial production.

Description

A kind of preparation method of Ceritinib intermediate
Technical field
The present invention relates to a kind of synthetic method of organic compound, in particular to a kind of preparation side of Ceritinib intermediateMethod.
Background technique
The anticarcinogen of Ceritinib (Ceritinib) April in 2014 of FDA on the 29th approval.Ceritinibshi is that ALK inhibitsAgent (Anaplastic Lymphoma Kinase), for sb.'s illness took a turn for the worse after crizotinib is treated or to crizotinib notThe treatment of positive (ALK+) Metastatic Nsclc (NSCLC) patient of the anaplastic lymphoma kinase of tolerance.Trade nameZykadia is researched and developed by Novartis.
The synthesis of Ceritinib convergence method first synthesizes the close segment of two molecular weight, then by two fragment assembliesInto (JMC, 2013,5675).First segment is reacted to obtain 2,2 Hes through SNAr with isopropanol after nitrification since compound 13 after Suzuki is coupled PtO2Segment 4 is obtained at salt after catalytic hydrogen reduction nitro.Another segment is since compound 5It is equally reacted through SNAr with isopropyl mercaptan, reoxidizes thioether to sulfone, rear reduction nitro obtains 6,6 and reacts to obtain 8 through SNAr with 7.
Above-mentioned synthetic method, route is longer, and yield is low;PtO is used in reaction2Catalytic hydrogenation, it is at high cost.
The applicant has applied for a kind of patent of invention of the preparation method of entitled Ceritinib on September 30th, 2014,Application No. is: 201410523385.X, this method, which prepares Ceritinib, only needs three-step reaction, and reaction route is short, and applicant is into oneStep research obtains the synthetic route for more preferably, being more suitable for industrialized production.
Summary of the invention
The purpose of the present invention is: it solves the problems, such as Ceritinib intermediate synthesis in the prior art, provides a kind of more suitableIndustrialized production is closed, cost is lower, is more easier the preparation method of the Ceritinib intermediate of operation.
Realizing the technical solution of the object of the invention is:
A kind of preparation method of Ceritinib intermediate includes the following steps: the bromo- 2- isopropoxy -5- methylbenzene of (1) 4-Amine is reacted with aceticanhydride generates N- (the bromo- 2- isopropoxy -5- tolyl of 4-) acetamide;It is preferred that the step (1) is in reaction flaskGlacial acetic acid is added in the middle bromo- 2- isopropoxy -5- methylaniline of loading 4- at room temperature, opens stirring, and aceticanhydride is added dropwise, then heatsReflux, is cooled to room temperature, is poured into ice water, stirs, and filters, washing, dry N- (the bromo- 2- isopropoxy -5- toluene of 4-Base) acetamide.
(2) N- benzyl -4- piperidones is generated by 4- piperidines reactive ketone;Preferred steps (2) are to sequentially add in reaction flask4- piperidones, potassium carbonate, DMF open stirring, stir at room temperature, and chlorobenzene is added dropwise, drips, is heated to 80 DEG C and keeps the temperature, thenIt is cooled to room temperature, water is added, stirring is extracted with ethyl acetate, and ethyl acetate layer is washed with salt, and it is dry with anhydrous sodium sulfate, subtractPressure concentration, obtains crude product, and methanol is added: chloroform=2:98 purification obtains this step product.
(3) N- (the bromo- 2- isopropoxy -5- tolyl of 4-) acetamide carries out docking with N- benzyl -4- piperidones and reacts;It is excellentStep (3) is selected to be packed into magnesium chips, anhydrous THF and compound N-(the bromo- 2- isopropoxy -5- tolyl of 4-) in dry reaction flask1,2- Bromofume is added under nitrogen protection for acetamide, heats initiation reaction, dropwise additionization compound N-(the bromo- 2- isopropyl oxygen of 4-Base -5- tolyl) acetamide, it is dissolved in the solution of anhydrous THF, keeps slightly boiled reflux, TLC detection compound N- (the bromo- 2- isopropyl of 4-Oxygroup -5- tolyl) acetamide fully reacting, it is spare to be cooled to room temperature;Above-mentioned reaction solution is cooled to 0-5 DEG C, chemical combination is added dropwiseObject N- benzyl -4- piperidones is dissolved in the solution of THF, keeps interior temperature to be no more than 10 DEG C, is stirred at room temperature after adding, TLC detection reactionCompletely, saturation NH is added4THF is concentrated under reduced pressure in Cl aqueous solution quenching reaction, and residue is extracted with toluene, and organic phase merges, washingIt is spare.
(4) preceding step reaction product is subjected to decarboxylation reaction and generates N- (4- (1- benzyl -1,2,3,6- tetrahydropyridine -4-Base) -2- isopropoxy -5- tolyl) acetamide;Preferred steps (4) are that TSOHH is added into above-mentioned toluene solution2O, nitrogenTemperature rising reflux under gas shielded is generated with fraction water device water-dividing to no water, TLC detect fully reacting, cool to 40 DEG C hereinafter,Na2CO3Aqueous solution washing, salt washing, Na2SO4Dry, concentration and recovery toluene, residue recrystallizes to produce with toluene/petroleum etherProduct.
(5) N- (4- (1- benzyl -1,2,3,6- tetrahydropyridine -4- base) -2- isopropoxy -5- tolyl) acetamide is existedFinal product 2- isopropoxy -5- methyl -4- piperidines-aniline, i.e. Ceritinib intermediate is generated in the presence of catalyst;It is preferred that walkingSuddenly (5) are that N- (4- (1- benzyl -1,2,3,6- tetrahydropyridine -4- base) -2- isopropoxy -5- tolyl) is added in autoclaveAcetamide, 5%pd/c, methanol, in certain temperature and pressure 3Kg pressure, 50 DEG C of reactions, middle control raw material fully reacting, suction filtration is goneExcept pd/c, methanol is concentrated under reduced pressure to there is solid precipitation, cooling filters to obtain product 2- isopropoxy -5- methyl -4- (piperidin-4-yl)Aniline.
The present invention has the effect of positive: the present invention develops the new preparation method of Ceritinib intermediate, the synthesisRoute cost is lower, and raw material is easy to get at low cost, and each portion's reaction condition is easily controllable as mild as a dove, is more suitable large-scaleIndustrial production.
Specific embodiment
(embodiment 1)
Step 1: the bromo- 2- isopropoxy -5- methylaniline (56G, 231.1mmol) of 4- is packed into 1000ml reaction flask,At room temperature plus in 200ml glacial acetic acid, stirring is opened, is added dropwise aceticanhydride (26.2ml, 277mmol), reflux 30min is then heated to,It is cooled to room temperature, is poured into 500ml ice water, stir 10min, filter, washing, dry N- (the bromo- 2- isopropoxy -5- of 4-Tolyl) acetamide 62.7g (95% yield).
Step 2: 4- piperidones (99.13g, 1mol) is sequentially added in 2000ml reaction flask, potassium carbonate (138g,1mol), DMF 500ml opens stirring, stirs 30min at room temperature, is added dropwise chlorobenzene (112g, 1mol), drips, be heated to 80 °And 5H is kept the temperature, it is then cooled to room temperature, adds 1000ml water, stirs 30min, is extracted with ethyl acetate 800ml*3, ethyl acetate layerIt is washed 2 times with 300ml salt, has anhydrous sodium sulfate dry, be concentrated under reduced pressure, obtain crude product, methanol is added: chloroform=2:98 is exquisite, obtainsProduct 175g. (yield=92.6%).
Step 3: it is packed into magnesium chips (2.88G, 0.12mol) in 500ml dry there-necked flask, anhydrous THF (10ML) and changeObject N- (the bromo- 2- isopropoxy -5- tolyl of 4-) acetamide (2.86g, 0.01mol) is closed, 1,2- dibromo is added under nitrogen protectionEthane (0.5g) heats initiation reaction, dropwise additionization compound N-(the bromo- 2- isopropoxy -5- tolyl of 4-) acetamide(25.74g, 0.09mol) is dissolved in the solution of the anhydrous THF of 90ML, keeps slightly boiled reflux 3H, TLC detection compound N- (the bromo- 2- of 4-Isopropoxy -5- tolyl) acetamide fully reacting, it is spare to be cooled to room temperature.
Above-mentioned reaction solution is cooled to 0-5 DEG C, compound N-benzyl -4- piperidones (19g, 0.1mol) is added dropwise and is dissolved inThe solution of 50MLTHF keeps interior temperature to be no more than 10 DEG C, is stirred at room temperature after adding 1 hour, and TLC detects fully reacting.It is added100ML is saturated NH4THF is concentrated under reduced pressure in Cl aqueous solution quenching reaction, and residue extracts (100Ml*3) with toluene, organic to be harmoniousAnd it washes spare.
Step 4: TSOHH is added into above-mentioned toluene solution2O (855mg, 4.5mmol) heats up back under nitrogen protectionStream, is generated with fraction water device water-dividing to no water, and TLC detects fully reacting, cools to 40 DEG C hereinafter, Na2CO3Aqueous solution washing, saltWashing, Na2SO4 is dry, concentration and recovery toluene, and residue recrystallizes to obtain product the 29g, (reason of total recovery 85% with toluene/petroleum etherBy 34G).
Step 5: N- (4- (1- phenyl -1,2,3,6- tetrahydropyridine -4- base) -2- isopropyl is added in 1000L autoclaveOxygroup -5- tolyl) acetamide (37.8g, 0.1mol), 5%pd/c 1g, 300ml methanol, 3kg pressure, 50 degree of reaction 2Hr,Middle control raw material fully reacting filters removal Pd/C, methanol is concentrated under reduced pressure to there is solid wash-off, cooling filters to obtain product 2- isopropyl oxygenBase -5- methyl -4- piperidines-aniline 235g (yield 95%).
(embodiment 2)
Step 1: the bromo- 2- isopropoxy -5- methylaniline (56G, 231.1mmol) of 4- is packed into 1000ml reaction flask,At room temperature plus in 200ml glacial acetic acid, stirring is opened, is added dropwise aceticanhydride (26.2ml, 277mmol), reflux 45min is then heated to,It is cooled to room temperature, is poured into 500ml ice water, stir 10min, filter, washing, dry N- (the bromo- 2- isopropoxy -5- of 4-Tolyl) acetamide 62.7g (95% yield).
Step 2: 4- piperidones (99.13g, 1mol) is sequentially added in 2000ml reaction flask, potassium carbonate (138g,1mol), DMF 500ml opens stirring, stirs 30min at room temperature, is added dropwise chlorobenzene (112g, 1mol), drips, be heated to 80 °And 6H is kept the temperature, it is then cooled to room temperature, adds 1000ml water, stirs 60min, is extracted with ethyl acetate 800ml*3, ethyl acetate layerIt is washed 2 times with 300ml salt, has anhydrous sodium sulfate dry, be concentrated under reduced pressure, obtain crude product, methanol is added: chloroform=2:98 is exquisite, obtainsProduct 175g. (yield=92.6%).
Step 3: it is packed into magnesium chips (2.88G, 0.12mol) in 500ml dry there-necked flask, anhydrous THF (10ML) and changeObject N- (the bromo- 2- isopropoxy -5- tolyl of 4-) acetamide (2.86g, 0.01mol) is closed, 1,2- dibromo is added under nitrogen protectionEthane (0.5g) heats initiation reaction, dropwise additionization compound N-(the bromo- 2- isopropoxy -5- tolyl of 4-) acetamide(25.74g, 0.09mol) is dissolved in the solution of the anhydrous THF of 90ML, keeps slightly boiled reflux 3.5H, (4- is bromo- by TLC detection compound N-2- isopropoxy -5- tolyl) acetamide fully reacting, it is spare to be cooled to room temperature.
Above-mentioned reaction solution is cooled to 0-5 DEG C, compound N-benzyl -4- piperidones (19g, 0.1mol) is added dropwise and is dissolved inThe solution of 50MLTHF keeps interior temperature to be no more than 10 DEG C, is stirred at room temperature after adding 1 hour, and TLC detects fully reacting.It is added100ML is saturated NH4THF is concentrated under reduced pressure in Cl aqueous solution quenching reaction, and residue extracts (100Ml*3) with toluene, organic to be harmoniousAnd it washes spare.
Step 4: TSOHH is added into above-mentioned toluene solution2O (855mg, 4.5mmol) heats up back under nitrogen protectionStream, is generated with fraction water device water-dividing to no water, and TLC detects fully reacting, cools to 40 DEG C hereinafter, Na2CO3Aqueous solution washing, saltWashing, Na2SO4 is dry, concentration and recovery toluene, and residue recrystallizes to obtain product the 29g, (reason of total recovery 85% with toluene/petroleum etherBy 34G).
Step 5: N- (4- (1- phenyl -1,2,3,6- tetrahydropyridine -4- base) -2- isopropyl is added in 1000L autoclaveOxygroup -5- tolyl) acetamide (37.8g, 0.1mol), 5%pd/c 1g, 300ml methanol, 3kg pressure, 50 degree of reaction 2H, inRaw material fully reacting is controlled, removal Pd/C is filtered, methanol is concentrated under reduced pressure to there is solid wash-off, cooling filters to obtain product 2- isopropyl oxygenBase -5- methyl -4- piperidines-aniline 235g (yield 95%).
Particular embodiments described above has carried out further in detail the purpose of the present invention, technical scheme and beneficial effectsIt describes in detail bright, it should be understood that the above is only a specific embodiment of the present invention, is not intended to restrict the invention, it is allWithin the spirit and principles in the present invention, any modification, equivalent substitution, improvement and etc. done should be included in guarantor of the inventionWithin the scope of shield.

Claims (5)

3. the preparation method of Ceritinib intermediate according to claim 1, it is characterised in that: the step (3) beMagnesium chips, anhydrous THF and compound N-(the bromo- 2- isopropoxy -5- tolyl of 4-) acetamide, nitrogen are packed into dry reaction flaskProtection is lower to be added 1,2- Bromofume, heats initiation reaction, compound N-(the bromo- 2- isopropoxy -5- tolyl of 4-) second is added dropwiseAmide is dissolved in the solution of anhydrous THF, keeps slightly boiled reflux, TLC detection compound N- (the bromo- 2- isopropoxy -5- tolyl of 4-)Acetamide fully reacting, it is spare to be cooled to room temperature;Above-mentioned reaction solution is cooled to 0-5 DEG C, compound N-benzyl -4- piperidines is added dropwiseKetone is dissolved in the solution of THF, keeps interior temperature to be no more than 10 DEG C, stirs at room temperature after adding, and TLC detects fully reacting, is added and is saturatedNH4THF is concentrated under reduced pressure in Cl aqueous solution quenching reaction, and residue is extracted with toluene, and organic phase merges, and washes spare.
CN201510651796.1A2015-10-102015-10-10A kind of preparation method of Ceritinib intermediateActiveCN106565593B (en)

Priority Applications (1)

Application NumberPriority DateFiling DateTitle
CN201510651796.1ACN106565593B (en)2015-10-102015-10-10A kind of preparation method of Ceritinib intermediate

Applications Claiming Priority (1)

Application NumberPriority DateFiling DateTitle
CN201510651796.1ACN106565593B (en)2015-10-102015-10-10A kind of preparation method of Ceritinib intermediate

Publications (2)

Publication NumberPublication Date
CN106565593A CN106565593A (en)2017-04-19
CN106565593Btrue CN106565593B (en)2019-03-01

Family

ID=58507366

Family Applications (1)

Application NumberTitlePriority DateFiling Date
CN201510651796.1AActiveCN106565593B (en)2015-10-102015-10-10A kind of preparation method of Ceritinib intermediate

Country Status (1)

CountryLink
CN (1)CN106565593B (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication numberPriority datePublication dateAssigneeTitle
CN115215788B (en)*2022-08-242023-09-22苏州凯瑞医药科技有限公司Preparation method of ceritinib key intermediate

Citations (5)

* Cited by examiner, † Cited by third party
Publication numberPriority datePublication dateAssigneeTitle
EP2091918B1 (en)*2006-12-082014-08-27Irm LlcCompounds and compositions as protein kinase inhibitors
CN104356050A (en)*2014-09-302015-02-18常州市勇毅生物药业有限公司Preparation method of ceritinib
CN104356112A (en)*2014-10-302015-02-18南京奇可医药化工有限公司Method for preparing ceritinib
CN104447515A (en)*2014-11-072015-03-25药源药物化学(上海)有限公司New intermediates for preparing ceritinib and preparation method of intermediate
CN104803908A (en)*2015-03-262015-07-29药源药物化学(上海)有限公司Hydrate of 2-isopropoxy-5-methyl-4-(4-piperidyl) aniline dihydrochloride as well as preparation method and application of hydrate

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication numberPriority datePublication dateAssigneeTitle
EP2091918B1 (en)*2006-12-082014-08-27Irm LlcCompounds and compositions as protein kinase inhibitors
CN104356050A (en)*2014-09-302015-02-18常州市勇毅生物药业有限公司Preparation method of ceritinib
CN104356112A (en)*2014-10-302015-02-18南京奇可医药化工有限公司Method for preparing ceritinib
CN104447515A (en)*2014-11-072015-03-25药源药物化学(上海)有限公司New intermediates for preparing ceritinib and preparation method of intermediate
CN104803908A (en)*2015-03-262015-07-29药源药物化学(上海)有限公司Hydrate of 2-isopropoxy-5-methyl-4-(4-piperidyl) aniline dihydrochloride as well as preparation method and application of hydrate

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
色瑞替尼( ceritinib);葛丹丹等;《中国药物化学杂志》;20141020;第24卷(第5期);第420页

Also Published As

Publication numberPublication date
CN106565593A (en)2017-04-19

Similar Documents

PublicationPublication DateTitle
CN109320498B (en)Preparation method of 3-bromo-1- (3-chloro-2-pyridyl) -1H-pyrazole-5-alkyl formate
CN104356050B (en)Preparation method of ceritinib midbody
CN108558747A (en)A kind of preparation method of Rui Gefeini
Che et al.Catalytic asymmetric oxidation of 1H-benzimidazolyl pyridinylmethyl sulfides with cumene hydroperoxide catalyzed by a titanium complex with (S, S)-N, N′-dibenzyl tartramide ligand
CN106565593B (en)A kind of preparation method of Ceritinib intermediate
CN104016924A (en)One-pot method for synthetizing enzalutamide
CN103788069B (en)The preparation method of esomeprazole magnesium trihydrate
CN110668967B (en)Photocatalytic preparation method of alpha-ketoamide compound
CN106432059A (en)Preparation method of 3-hydroxypiperidine, preparation method of derivative of 3-hydroxypiperidine, and intermediate of 3-hydroxypiperidine
CN103694223B (en)A kind of one kettle way prepares the method for esomeprazole magnesium
CN101747284A (en)Method for preparing antioxidant
CN102120731B (en)Novel method for preparing 4-(3-chlorine-4-fluorophenylamino)-7-methoxyl-6-(3-morpholinepropoxy)quinazoline
CN104926900B (en)A kind of method of capecitabine intermediate shown in preparation formula I
CN103539750A (en)Synthesis process of rufinamide
CN110938008A (en)Preparation method of o-aminoacetophenone
CN106588693B (en)A kind of synthetic method of aryl azide compound
CN108997209A (en)A kind of preparation method of Rui Gefeini
ES2392998B2 (en) PROCEDURE FOR CATALYTIC REDUCTION OF NITROAROMATIC COMPOUNDS.
CN113956268B (en)6-bromo-1-chlorobenzothiophene [2,3-c ] pyridine and synthetic method
CN110903254B (en)Synthetic method of heterocyclic intermediate applied to JAK inhibitor drugs
CN107573301B (en)Preparation method of tricyclazole intermediate
CN100430381C (en) Method for preparing 3,5,6-trichloropyridin-2-alcohol sodium without solvent
CN107353250B (en)A kind of synthetic method of lorcaserin
CN109836425B (en)Preparation process of synthetic pemetrexed
CN103274996A (en)Method for preparing 3,5,6-trichloropyridin-2-ol sodium by improved one pot process

Legal Events

DateCodeTitleDescription
PB01Publication
PB01Publication
SE01Entry into force of request for substantive examination
SE01Entry into force of request for substantive examination
GR01Patent grant
GR01Patent grant

[8]ページ先頭

©2009-2025 Movatter.jp